Catecholaminergic polymorphic ventricular tachycardia

[1]. Andreas Pflaumer, et al. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia. Heart Lung Circ. 2012 Feb;21(2):96-100. [Content Brief]

[2]. Guy Katz, et al. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Curr Probl Cardiol. 2009 Jan;34(1):9-43. [Content Brief]

[3]. H Lahat, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001 Dec;69(6):1378-84. [Content Brief]

[4]. Harsha D Devalla, et al. TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT. EMBO Mol Med. 2016 Dec 1;8(12):1390-1408. [Content Brief]

[5]. Mette Nyegaard, et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet. 2012 Oct 5;91(4):703-12. [Content Brief]

[6]. Nathalie Roux-Buisson, et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. Hum Mol Genet. 2012 Jun 15;21(12):2759-67. [Content Brief]

[7]. Nian Liu, et al. Catecholaminergic polymorphic ventricular tachycardia. Herz. 2007 May;32(3):212-7. [Content Brief]

[8]. Nieves Gomez-Hurtado, et al. Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks. Circ Arrhythm Electrophysiol. 2016 Aug;9(8):10.1161/CIRCEP.116.004161 e004161. [Content Brief]

[9]. S G Priori, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001 Jan 16;103(2):196-200. [Content Brief]